Who Owns ProQR Therapeutics N.V. Stock?
NASDAQ: PRQRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 55.27%
- Held by insiders
- 17.46%
- Institutional holders
- 81
- Institutions 55.3%
- Insiders 17.5%
- Public and other 27.3%
Who owns ProQR Therapeutics N.V. stock?
Institutional investors own about 55.3% of ProQR Therapeutics N.V.'s shares, spread across 81 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 17.46% of PRQR.
The largest institutional holders are Aberdeen Group plc (9.18%), Adage Capital Partners GP L.L.C. (8.56%) and Privium Fund Management B.V. (5.19%). Together, the top 10 institutions control 39.0% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their PRQR positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PRQR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Aberdeen Group plc | 9.67M | 9.18% | +8.2% |
| Adage Capital Partners GP L.L.C. | 9.02M | 8.56% | 0.0% |
| Privium Fund Management B.V. | 5.47M | 5.19% | -1.0% |
| Affinity Asset Advisors, Llc | 4.97M | 4.72% | -10.3% |
| Ikarian Capital, LLC | 3.43M | 3.25% | 0.0% |
| 683 Capital Management LLC | 2.05M | 1.95% | +47.2% |
| Sphera Funds Management Ltd. | 1.76M | 1.67% | 0.0% |
| Kynam Capital Management, LP | 1.57M | 1.49% | 0.0% |
| Lynx1 Capital Management Lp | 1.56M | 1.48% | +199.6% |
| Woodline Partners LP | 1.56M | 1.48% | -52.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PRQR
| Fund | Shares | % Held |
|---|---|---|
| abrdn World Healthcare Fund | 6.31M | 5.99% |
| abrdn Life Sciences Investors | 2.62M | 2.49% |
| Delaware Group Equity Funds IV-Nomura Healthcare Fund | 620.00K | 0.59% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 23.86K | 0.02% |
| TIFF INVESTMENT PROGRAM-TIFF Multi-Asset Fund | 22.14K | 0.02% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 7.60K | 0.01% |
| ADVISORS' INNER CIRCLE III-Knights of Columbus U.S. All Cap Index Fund | 405 | 0.00% |
Frequently asked questions
Who is the largest shareholder of ProQR Therapeutics N.V.?
Aberdeen Group plc is the largest institutional shareholder of PRQR, owning 9.18% of shares outstanding (9.67M shares) as of its latest 13F filing.
What percentage of ProQR Therapeutics N.V. is owned by institutions?
Institutions own about 55.3% of PRQR shares and 67.0% of the public float.
How much of ProQR Therapeutics N.V. do insiders own?
Insiders, such as officers and directors, own about 17.46% of PRQR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.